CSET’s Steph Batalis shared her expert insight in an article published by TIME. The article examines how leading AI companies are increasingly restricting access to their most capable models, such as GPT-Rosalind and Claude Mythos, due to growing concerns around dual-use risks in areas like cybersecurity and biological research, and the broader question of who should govern access to these systems.
We know that people want to, and do, commit cyber attacks. We just don’t have that same sample size with the biological risks.CSET Research Fellow, Steph Batalis
Discussing the difficulty of assessing biological risk compared to cyber risk, Batalis said, “We know that people want to, and do, commit cyber attacks”. She added, “We just don’t have that same sample size with the biological risks.”
To read the full article, visit TIME.